RamiroGarzonMD
Hematology • Salt Lake City, UTAssociate Professor, Internal Medicine, Ohio State University College of Medicine
Dr. Garzon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1950 Circle of Hope Dr 4126
Salt Lake City, UT 84112Phone+1 801-581-2121Fax+1 614-293-7526
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2002 - 2005
Danbury HospitalResidency, Internal Medicine, 1999 - 2002
Universidad Nacional de CordobaClass of 1994
Certifications & Licensure
UT State Medical License 2022 - 2026
OH State Medical License 2005 - 2023
PA State Medical License 2002 - 2006
Clinical Trials
- Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia Start of enrollment: 2010 Aug 01
- Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease Start of enrollment: 2012 Feb 20
- AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia Start of enrollment: 2013 Sep 17
- Join now to see all
Publications & Presentations
PubMed
- 18 citationsMutations associated with a 17-gene leukemia stem cell score and the score's prognostic relevance in the context of the European LeukemiaNet classification of acute my...Marius Bill, Deedra Nicolet, Jessica Kohlschmidt, Christopher J. Walker, Krzysztof Mrózek
Haematologica. 2020-03-01 - 469 citationsBiological Functions of miR-29b Contribute to Positive Regulation of Osteoblast DifferentiationZhaoyong Li, Mohammad Q. Hassan, Mohammed Jafferji, Rami I. Aqeilan, Ramiro Garzon
The Journal of Biological Chemistry. 2009-06-05 - 1867 citationsA MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic LeukemiaGeorge A. Calin, Manuela Ferracin, Amelia Cimmino, Gianpiero Di Leva, Masayoshi Shimizu
The New England Journal of Medicine. 2005-10-27
Abstracts/Posters
- Distinct Gene Expression Profiles and Mutations Associate with Outcome in Younger Adults with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (Alliance)Ramiro Garzon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia (AML)Ramiro Garzon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Personalized Oncology in Acute Myeloid Leukemia (AML): Validation of the Prognostic Value of the Knowledge Bank Algorithm in Patients (Pts) Treated on Cancer and Leuke...Ramiro Garzon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
Long Noncoding RNAs: Novel Prognostic Marker in Older Patients with Acute LeukemiaDecember 15th, 2014- Inhibitors of Shuttle Molecule Show Promise in Acute LeukemiaJune 19th, 2012
Huntsman Cancer Institute Researchers Find Link Between Folic Acid and Blood Cell ProductionDecember 15th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
